AI Article Synopsis
- This study analyzes how time and region impact U.S. college students' views and intentions about marital naming.
- Data collected from two different periods at universities in the Midwest and East shows no change over time in women's plans to keep their birth names in marriage.
- However, attitudes shifted, with Midwest women in 2006 being more likely to associate a husband's last name with commitment compared to their peers in 1990, suggesting a trend towards conservatism.
- Additionally, women from the East showed a greater inclination to retain their birth surnames compared to those from the Midwest.
Article Abstract
This study examines time period and regional effects on U.S. college students' attitudes and plans regarding marital naming. Data were gathered at a Midwestern college in 1990 and 2006 and at an Eastern university in 2006 (=867). No time period effect was identified for marital name plans in the Midwest samples. Women were neither more nor less likely to plan to retain their birth name in 1990 as compared to 2006. A time period effect was found for attitudes: Midwest women in 2006 were more likely to say a woman was more committed to the marriage if she took her husband's last name as compared to Midwest women in 1990. This indicates that women in the Midwest may have become more conservative over time. We also found regional differences: women in the East were significantly more likely than women in the Midwest to plan to keep their birth surname upon marriage. Findings suggest a trend toward more conservative attitudes over time and location although plans, perhaps due to the rareness of maintaining a birth surname upon marriage, have not changed.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170063 | PMC |
| http://dx.doi.org/10.1007/s11199-011-0089-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Robotic bronchoscopy: Evolution of advanced diagnostic technologies for pulmonary lesions.
Best Pract Res Clin Anaesthesiol
March 2024
1400 Holcombe Blvd, FC 13.2000, Houston, TX, 77030, USA. Electronic address:
Lung cancer is among one of the most commonly diagnosed malignancies and is the leading cause of cancer-related mortality in both men and women globally, with an estimated 1.8 million deaths annually. Moreover, it is also the leading cause of cancer related deaths in the United States (U.
View Article and Find Full Text PDFDifferent Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study.
J Diabetes Sci Technol
January 2025
Unit of Endocrine Diseases and Diabetology, Department of Medicine, ASST Papa Giovanni XXIII, Bergamo, Italy.
Aims: According to the 2023 International Consensus, glucose metrics derived from two-week-long continuous glucose monitoring (CGM) can be extrapolated up to 90 days before. However, no studies have focused on adults with type 1 diabetes (T1D) on multiple daily injections (MDIs) and with second-generation intermittently scanned CGM (isCGM) sensors in a real-world setting.
Methods: This real-world, retrospective study included 539 90-day isCGM data from 367 adults with T1D on MDI therapy.
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.
EClinicalMedicine
October 2024
Centre for Psychedelic Research, Division of Psychiatry, Department Brain Sciences, Imperial College London, United Kingdom.
Background: Psilocybin therapy (PT) produces rapid and persistent antidepressant effects in major depressive disorder (MDD). However, the long-term effects of PT have never been compared with gold-standard treatments for MDD such as pharmacotherapy or psychotherapy alone or in combination.
Methods: This is a 6-month follow-up study of a phase 2, double-blind, randomised, controlled trial involving patients with moderate-to-severe MDD.
L-arginine in patients with spinocerebellar ataxia type 6: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
EClinicalMedicine
December 2024
Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
Background: Therapeutic advancements for the polyglutamine diseases, particularly spinocerebellar degeneration, are eagerly awaited. We evaluated the safety, tolerability, and therapeutic effects of L-arginine, which inhibits the conformational change and aggregation of polyglutamine proteins, in patients with spinocerebellar ataxia type 6 (SCA6).
Methods: A multicenter, randomized, double-blind, placebo-controlled phase 2 trial (clinical trial ID: AJA030-002, registration number: jRCT2031200135) was performed on 40 genetically confirmed SCA6 patients enrolled between September 1, 2020, and September 30, 2021.
Experimental revival of an unknown state from the past in quantum walks.
Natl Sci Rev
January 2025
Beijing Computational Science Research Center, Beijing 100193, China.
The physical process in the macroscopic world unfolds along a single time direction, while the evolution of a quantum system is reversible in principle. How to recover a quantum system to its past state is a complex issue of both fundamental and practical interests. In this article, we experimentally demonstrate a novel method for recovering the state in quantum walks (QWs), also known as full-state revival.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!